Does β-Hexosaminidase Function Only as a Degranulation Indicator in Mast Cells? The Primary Role of β-Hexosaminidase in Mast Cell Granules

β-Hexosaminidase, which is generally present in the lysosome, is essential for glycoprotein metabolism in the maintenance of cell homeostasis. In mast cells (MCs), large amounts of β-hexosaminidase are present in the granules as opposed to the lysosome, and the biological role of MC β-hexosaminidase has yet to be fully elucidated. Therefore, we investigated the biological role of β-hexosaminidase in MC granules. Bone marrow-derived MCs from C57BL/6 (BL/6-BMMC) or β-hexosaminidase gene–deficient (hexb−/−-BMMC) mice were transplanted into MC-deficient (WBB6F1/J-KitW/KitW-v [W/Wv]) mice to generate MC-reconstituted models. In asthma model experiments, no differences were observed in the symptoms of BL/6, W/Wv, BL/6-BMMC–reconstituted W/Wv, or hexb−/−-BMMC–reconstituted W/Wv mice. In Staphylococcus epidermidis experimental infection model experiments, the severity of symptoms and frequency of death were markedly higher in W/Wv and hexb−/−-BMMC–reconstituted W/Wv mice than in BL/6 and BL/6-BMMC–reconstituted W/Wv mice. The growth of S. epidermidis in an in vitro study was clearly inhibited by addition of BL/6-BMMC lysate, but not by addition of hexb−/−-BMMC lysate. Moreover, suppression of bacterial proliferation was completely recovered when bacteria were incubated with hexb−/−-BMMC lysate plus β-hexosaminidase. Transmission electron microscopy indicated that the cell wall of S. epidermidis was heavily degraded following coincubation of bacteria with BL/6-BMMC lysate, but not following coincubation with hexb−/−-BMMC lysate. These findings strongly suggest that MC granule β-hexosaminidase is crucial for defense against bacterial invasion, but is not involved in the allergic response. Our results also suggest that the bactericidal mechanism of β-hexosaminidase involves degradation of bacterial cell wall peptidoglycan.

[1]  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.

[2]  Calman Prussin,et al.  IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.

[3]  Ping Wu,et al.  Role for lysosomal enzyme β-hexosaminidase in the control of mycobacteria infection , 2008, Proceedings of the National Academy of Sciences.

[4]  R. Paus,et al.  IL-15 constrains mast cell–dependent antibacterial defenses by suppressing chymase activities , 2007, Nature Medicine.

[5]  Y. Li,et al.  Studies on the glycosidases in jack bean meal. II. Sepation of various glycosidases by isoelectric focusing. , 1968, The Journal of biological chemistry.

[6]  H. Labischinski,et al.  Chapter 2 Bacterial peptidoglycan: overview and evolving concepts , 1994 .

[7]  R. Proia,et al.  The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse. , 1997, Annals of medicine.

[8]  J. Drazen,et al.  Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung* , 2001, The Journal of Biological Chemistry.

[9]  Steven D. Douglas Analytic review: disorders of phagocyte function. , 1970, Blood.

[10]  K. Austen,et al.  Enzymes of the mast cell granule. , 1980, The Journal of investigative dermatology.

[11]  G. Berry,et al.  CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. , 2006, The New England journal of medicine.

[12]  Y. Jigami,et al.  Molecular pathologies of and enzyme replacement therapies for lysosomal diseases. , 2006, CNS & neurological disorders drug targets.

[13]  T. Zuberbier,et al.  Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. , 2007, The American journal of pathology.

[14]  K. Tasaka,et al.  Antiallergic effects of terfenadine on immediate type hypersensitivity reactions. , 1987, Immunopharmacology and immunotoxicology.

[15]  L. Groebe,et al.  The multiple mechanisms of Ca2+ signalling by listeriolysin O, the cholesterol‐dependent cytolysin of Listeria monocytogenes , 2007, Cellular microbiology.

[16]  K. Takechi,et al.  Plastid peptidoglycan. , 2010, Biochimica et biophysica acta.

[17]  R. Schiffmann,et al.  Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources , 1995, Annals of Internal Medicine.

[18]  P. Stock,et al.  Recent advances in the role of NKT cells in allergic diseases and asthma , 2008, Current allergy and asthma reports.

[19]  M. Olivier,et al.  Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. , 2009, The Journal of infectious diseases.

[20]  P. A. van der Merwe,et al.  The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Bachert,et al.  Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. , 2008, The Journal of allergy and clinical immunology.

[22]  B. Zweiman,et al.  The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. , 1995, The Journal of clinical investigation.

[23]  Gunnar Pejler,et al.  Mast cell proteases: multifaceted regulators of inflammatory disease. , 2010, Blood.

[24]  D. Mahuran,et al.  Lending a helping hand, screening chemical libraries for compounds that enhance β‐hexosaminidase A activity in GM2 gangliosidosis cells , 2007, The FEBS journal.

[25]  G. Caughey Mast cell tryptases and chymases in inflammation and host defense , 2007, Immunological reviews.

[26]  R. Stevens,et al.  Protease–proteoglycan complexes of mouse and human mast cells and importance of their β‐tryptase–heparin complexes in inflammation and innate immunity , 2007, Immunological reviews.

[27]  S. Bhakdi,et al.  Mast cells determine the magnitude of bacterial toxin‐induced skin inflammation , 2009, Experimental dermatology.

[28]  R. Dwek,et al.  Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis , 2002, Neuropathology and applied neurobiology.

[29]  D. Metcalfe,et al.  Sounding the Alarm in Infection , 2004 .

[30]  C. Janeway,et al.  Evolution of the innate immune system , 2001 .

[31]  R. Proia,et al.  Physiological Substrates for Human Lysosomal β-Hexosaminidase S* , 2002, The Journal of Biological Chemistry.

[32]  Gudrun Brandes,et al.  Clostridium difficile Toxins A and B Directly Stimulate Human Mast Cells , 2007, Infection and Immunity.

[33]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[34]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[35]  D. Umetsu,et al.  Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity , 2003, Nature Medicine.

[36]  S. Kusumoto,et al.  Mitogenic Effects of Bacterial Cell Walls, Their Fragments, and Related Synthetic Compounds on Thymocytes and Splenocytes of Guinea Pigs , 1979, Infection and immunity.

[37]  H. Nakanishi,et al.  Tryptase Inhibition Blocks Airway Inflammation in a Mouse Asthma Model1 , 2002, The Journal of Immunology.

[38]  Michael P. McDonald,et al.  Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism , 1995, Nature Genetics.

[39]  P. A. Shore [259] Fluorometric assay of histamine☆ , 1971 .

[40]  D. Seldin,et al.  Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. , 1984, Journal of immunology.

[41]  M. Castells Mast cell mediators in allergic inflammation and mastocytosis. , 2006, Immunology and allergy clinics of North America.

[42]  D. Umetsu,et al.  Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma. , 2010, The Journal of allergy and clinical immunology.

[43]  K.,et al.  Tryptase from human pulmonary mast cells. Purification and characterization. , 1981, The Journal of biological chemistry.

[44]  S. Abraham,et al.  Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.

[45]  R. Djukanović,et al.  Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. , 2001, The Journal of allergy and clinical immunology.

[46]  T. Harada,et al.  Antimicrobial effects of Burow’s solution on Staphylococcus aureus and Pseudomonas aeruginosa , 2012, Medical Molecular Morphology.

[47]  M. Potier,et al.  Purification and some properties of liver and brain β-N-Acetyl-hexosaminidase S , 1979 .

[48]  N. Takemori,et al.  Ultrastructural evidence for the origin of mast cells in normal human bone marrow , 1991, American journal of hematology.

[49]  D. Tsuji,et al.  Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis , 2009, Journal of neurochemistry.

[50]  D. Tsuji,et al.  Production of Recombinant β-Hexosaminidase A, a Potential Enzyme for Replacement Therapy for Tay-Sachs and Sandhoff Diseases, in the Methylotrophic Yeast Ogataea minuta , 2007, Applied and Environmental Microbiology.

[51]  F. Gunzer,et al.  Selective Activation of Human Intestinal Mast Cells by Escherichia coli Hemolysin1 , 2008, The Journal of Immunology.

[52]  D. Metcalfe,et al.  IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. , 1993, Journal of immunology.

[53]  C. Tsai,et al.  Purification and Characterization , 2006 .